Pharmacodynamic Effects of Dabigatran in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
Latest Information Update: 11 Dec 2015
At a glance
- Drugs Dabigatran etexilate (Primary) ; Aspirin; Clopidogrel
- Indications Coronary artery disease; Myocardial infarction; Stroke; Thrombosis; Venous thromboembolism
- Focus Pharmacodynamics
- 03 Dec 2015 Primary endpoint has not been met. (TRAP-induced Platelet Aggregation), as published in the Thrombosis and Haemostasis
- 03 Dec 2015 Results published in the Thrombosis and Haemostasis
- 03 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.